245 related articles for article (PubMed ID: 29867973)
1. Lineage-Specific Functionality of an Interferon Regulatory Factor 5 Lupus Risk Haplotype: Lack of B Cell Intrinsic Effects.
Calise J; Marquez Renteria S; Gregersen PK; Diamond B
Front Immunol; 2018; 9():996. PubMed ID: 29867973
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus.
Cherian TS; Kariuki SN; Franek BS; Buyon JP; Clancy RM; Niewold TB
Arthritis Rheum; 2012 Oct; 64(10):3383-7. PubMed ID: 22674082
[TBL] [Abstract][Full Text] [Related]
3. IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.
Li D; Matta B; Song S; Nelson V; Diggins K; Simpfendorfer KR; Gregersen PK; Linsley P; Barnes BJ
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877114
[TBL] [Abstract][Full Text] [Related]
4. Effects of IRF5 lupus risk haplotype on pathways predicted to influence B cell functions.
Guthridge JM; Clark DN; Templeton A; Dominguez N; Lu R; Vidal GS; Kelly JA; Kauffman KM; Harley JB; Gaffney PM; James JA; Poole BD
J Biomed Biotechnol; 2012; 2012():594056. PubMed ID: 22500098
[TBL] [Abstract][Full Text] [Related]
5. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
[TBL] [Abstract][Full Text] [Related]
6. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
[TBL] [Abstract][Full Text] [Related]
7. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
[TBL] [Abstract][Full Text] [Related]
8. Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: analysis of multiple experiments with lymphoblastoid cell lines.
Alonso-Perez E; Suarez-Gestal M; Calaza M; Kwan T; Majewski J; Gomez-Reino JJ; Gonzalez A
Arthritis Res Ther; 2011 May; 13(3):R80. PubMed ID: 21627826
[TBL] [Abstract][Full Text] [Related]
9. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
Graham RR; Kozyrev SV; Baechler EC; Reddy MV; Plenge RM; Bauer JW; Ortmann WA; Koeuth T; González Escribano MF; ; Pons-Estel B; Petri M; Daly M; Gregersen PK; Martín J; Altshuler D; Behrens TW; Alarcón-Riquelme ME
Nat Genet; 2006 May; 38(5):550-5. PubMed ID: 16642019
[TBL] [Abstract][Full Text] [Related]
10. Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function.
Wen F; Ellingson SM; Kyogoku C; Peterson EJ; Gaffney PM
Autoimmunity; 2011 Mar; 44(2):82-9. PubMed ID: 20695768
[TBL] [Abstract][Full Text] [Related]
11. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
[TBL] [Abstract][Full Text] [Related]
12. IRF5-mediated signaling and implications for SLE.
Lazzari E; Jefferies CA
Clin Immunol; 2014 Aug; 153(2):343-52. PubMed ID: 24928322
[TBL] [Abstract][Full Text] [Related]
13. The
Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus.
Hammad A; Mossad YM; Nasef N; Eid R
Lupus; 2017 Jul; 26(8):871-880. PubMed ID: 28059021
[TBL] [Abstract][Full Text] [Related]
15. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.
Graham RR; Kyogoku C; Sigurdsson S; Vlasova IA; Davies LR; Baechler EC; Plenge RM; Koeuth T; Ortmann WA; Hom G; Bauer JW; Gillett C; Burtt N; Cunninghame Graham DS; Onofrio R; Petri M; Gunnarsson I; Svenungsson E; Rönnblom L; Nordmark G; Gregersen PK; Moser K; Gaffney PM; Criswell LA; Vyse TJ; Syvänen AC; Bohjanen PR; Daly MJ; Behrens TW; Altshuler D
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6758-63. PubMed ID: 17412832
[TBL] [Abstract][Full Text] [Related]
16. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.
Savitsky DA; Yanai H; Tamura T; Taniguchi T; Honda K
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10154-9. PubMed ID: 20479222
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.
Feng D; Stone RC; Eloranta ML; Sangster-Guity N; Nordmark G; Sigurdsson S; Wang C; Alm G; Syvänen AC; Rönnblom L; Barnes BJ
Arthritis Rheum; 2010 Feb; 62(2):562-73. PubMed ID: 20112383
[TBL] [Abstract][Full Text] [Related]
19. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
20. Opposed independent effects and epistasis in the complex association of IRF5 to SLE.
Ferreiro-Neira I; Calaza M; Alonso-Perez E; Marchini M; Scorza R; Sebastiani GD; Blanco FJ; Rego I; Pullmann R; Pullmann R; Kallenberg CG; Bijl M; Skopouli FN; Mavromati M; Migliaresi S; Barizzone N; Ruzickova S; Dostal C; Schmidt RE; Witte T; Papasteriades C; Kappou-Rigatou I; Endreffy E; Kovacs A; Ordi-Ros J; Balada E; Carreira P; Gomez-Reino JJ; Gonzalez A
Genes Immun; 2007 Jul; 8(5):429-38. PubMed ID: 17568788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
